Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Avelumab in patients with previously treated metastatic Merkel cell carcinoma (JAVELIN Merkel 200): updated overall survival data after >5 years of follow-up

Published:2021-12 Issue:6 Volume:6 Page:100290
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

D'Angelo S.P.,Bhatia S.,Brohl A.S.,Hamid O.,Mehnert J.M.,Terheyden P.,Shih K.C.,Brownell I.,Lebbé C.,Lewis K.D.,Linette G.P.,Milella M.,Xiong H.,Guezel G.,Nghiem P.T.

Funder

Merck

Merck KGaA

Pfizer

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference8 articles.

1. NCCN Clinical Practice Guidelines in Oncology. Merkel Cell Carcinoma. v1,2021

2. Analysis of prognostic factors from 9387 Merkel cell carcinoma cases forms the basis for the new 8th edition AJCC staging system;Harms;Ann Surg Oncol,2016

3. Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma;Iyer;Cancer Med,2016

4. Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe;Becker;Oncotarget,2017

5. Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA;Cowey;Future Oncol,2017

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merkel Cell Carcinoma;Hematology/Oncology Clinics of North America;2024-10

2. Treatment Effect Waning in Immuno-oncology Health Technology Assessments: A Review of Assumptions and Supporting Evidence with Proposals to Guide Modelling;PharmacoEconomics;2024-08-23

3. Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models;Frontiers in Oncology;2024-07-29

4. Immunotherapy in Neuroendocrine Neoplasms: A Diamond to Cut;Cancers;2024-07-13

5. Lack of Clinically Significant Relationships of Age or Body Mass Index with Merkel Cell Carcinoma Immunotherapy Outcomes;Cancers;2024-07-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3